Merge ventures into LIS market with Fletcher-Flora purchase

Justine Varieur Cadet | | Health Imaging | Enterprise Imaging
Merge Healthcare has acquired certain assets of Fletcher-Flora Healthcare Systems, including its lab information systems (LIS) product line.

This acquisition is Merge’s first foray into the LIS market. “We believe the addition of lab information systems product line is a natural extension of our portfolio that will lead to increased EHR adoption,” said Julie Pekarek, vice president of marketing at the Milwaukee-based Merge.

“We are pleased to announce Fletcher-Flora is now a part of the Merge family of health IT solutions,” according to a statement on the website of Fletcher-Flora, which is based in Anaheim, Calif.

According to Merge, those LIS products include the web-based FFlex eSuite LIS, the hosted version FFlex eSuite ASP, the entry-level package FFlex eSuite MGR, the FFlex eLink Integration Software, as well as the original lab software LabPak LIS.

Justine Varieur Cadet

Related Content

Less than half of incidental interstitial lung abnormalities on CT exams are reported
Are providers too trusting of AI's advice?
Pairing an alert system with CAD software halves time-to-treatment for pneumothorax
Patients without PCPs struggle to access lung cancer screening, despite eligibility
Rads are more accurate when they have access to patients' self-reported symptoms
AI-based software improves follow-up imaging adherence by 74%

Around the web

Cardiovascular Business
Positron partners with Upbeat Cardiology Solutions to improve cardiac PET/CT access

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.